OC3 - HealthTech & Biotech

Description

X2.0 - Driving Deep Tech Growth is an EU-funded deeptech growth program that seeks to ensure the scaling up of EU deeptech startups by providing custom, industry-focused, 5 months growth programs that will act as a catalyst in delivering market-ready applications and technology solutions in 5 key impact areas. The third impact area is HealthTech & BioTech. Benefits: Innovation Vouchers to cover: • Needs-based growth and scaling services in the max. amount of €20,000 • Access large-scale startup and investor-oriented events, exhibitions, and fairs in the amount of €5,000 • 1-on-1 mentorship with experts from the field of need in the min. amount of €5,000 Other Program Benefits • Corporate Matchmaking and procurement • Private Fundraising assistance • Custom EU funding and public procurement ecosystem and overview • Talent Matchmaking & Job promotion • Promotion & Visibility

Beneficiary & submission

The third X2.0 Open Call and its 5-month growth program aim to foster the launch, development, growth, and scaling of new products, services, processes, and integrated solutions in the HealthTech & BioTech domain. X2.0 is actively seeking startups, scaleups, and SMEs operating in the deeptech domain of HealthTech & BioTech. We are particularly interested in innovations that demonstrate significant scientific advances or high-tech solutions related to Digital Agenda technologies. Startups offering new diagnostics, devices, or therapy services for improved disease and infrastructure management, as well as advancements in care organization, are encouraged to apply. This includes areas such as physical and mental health, healthcare structure enhancements, biotechnologies for disease management, mobile health apps, wearable devices, telehealth, and telemedicine solutions. Additionally, startups involved in biopharmaceuticals, cell therapy, gene therapy, antimicrobial resistance, pain and addiction, drug development and lifecycle management, rare diseases, and orphan drugs, as well as vaccines and biodefense other aspects of HealthTech & BioTech are also invited to apply. Our highly selective and individually tailored program is looking for 10 deep-tech startups and SMEs to take part in the third growth program. The submission process consists in completing an application form available at F6S portal before the call deadline. The evaluation process is fully detailed in the Guidelines for Applicants and can be found on the Open Call Page. Please, carefully read them before submitting your proposal. Selection criteria: Economic and business potential (25%) Excellence (30%) Impact (30%) Special focus (10%) - Seal of Excellence holders, Startups are coming from Widening Countries or that have female entrepreneurs / founded or co-founded by women, holding a top management position (chief executive officer (CEO), chief technology officer (CTO), chief scientific officer (CSO), or equivalent). Motivation (5%) Evaluation will be performed by a mix of external and internal evaluators.

Further information

Register for the live Program Q&A webinar that happens on August 16 at 10.00 CET! Doubts or questions? Have a look at the FAQ section on our website,, or drop us an email via info@x2-0.eu